TIGIT and glioblastoma: By comparison to blocking and irrelevant antibody controls, the in vivo immunoPET imaging (Fig. 4) indicated that 89Zr-αTIGIT can specifically detect TIGIT-expressing cells in a murine model of GBM, at late timepoints.